Filing Flows › Bio Essence (BIOE) › Q1 2026 › vs Q4 2025
Bio Essence (BIOE) Q1 2026 vs Q4 2025 (quarter over quarter)
Bio Essence's revenue fell $979K (-66%) from $1.5M in Q4 2025 to $501K in Q1 2026. Gross margin 63.8% against 77.3% (-13.5 pts).
Bio Essence, Q1 2026: revenue $501K (23× year over year), operating margin 43.1%, net earnings $205K, operating cash flow −$412K. The chart draws each line against Q4 2025, the increases inside each band.
Margins
| Q1 2026 | Q4 2025 | Change | |
|---|---|---|---|
| Gross margin | 63.8% | 77.3% | -13.5 pts |
| Operating margin | 43.1% | 69.6% | -26.5 pts |
| Net margin | 41.0% | 69.6% | -28.5 pts |
Every line
| Line | Q1 2026 | Q4 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $501K | $1.5M | −$979K | -66% |
| Gross profit | $319K | $1.1M | −$824K | -72% |
| Cost of revenue | $181K | $336K | −$155K | -46% |
| Operating profit | $216K | $1.0M | −$814K | -79% |
| Operating expenses | $104K | $114K | −$10K | -9% |
| Pre-tax earnings | $215K | $1.0M | −$814K | -79% |
| Net earnings | $205K | $1.0M | −$824K | -80% |
| Income tax | $10K | $0 | $10K | — |
| Operating cash sources | $617K | −$212K | $829K | — |
| Depreciation & amortization | $59 | $59 | $0 | 0% |
| Cash used in operations | $412K | −$1.2M | $1.7M | — |
| Working capital & other | $617K | −$212K | $829K | — |
Questions
How much did Bio Essence's revenue grow quarter over quarter in Q1 2026?
Bio Essence's revenue fell $979K (-66%) from $1.5M in Q4 2025 to $501K in Q1 2026. Gross margin 63.8% against 77.3% (-13.5 pts).